Diagnostic accuracy of routine liver function tests to identify patients with significant and advanced alcohol-related liver fibrosis

References

• White AM, Castle I-JP, Hingson RW, et al. Using death certificates to explore changes in alcohol-related mortality in the United States, 1999 to 2017. Alcohol Clin Exp Res. 2020;44(1):178–187.
   PubMed Web of Science ®Google Scholar
• Parker R, Aithal GP, Becker U, et al. Natural history of histologically proven alcohol-related liver disease: a systematic review. J Hepatol. 2019;71(3):586–593.
   PubMed Web of Science ®Google Scholar
• Askgaard G, Leon DA, Kjaer MS, et al. Risk for alcoholic liver cirrhosis after an initial hospital contact with alcohol problems: a nationwide prospective cohort study. Hepatology. 2017;65(3):929–937.
   PubMed Web of Science ®Google Scholar
• Askgaard G, Neermark S, Leon DA, et al. Hospital contacts with alcohol problems prior to liver cirrhosis or pancreatitis diagnosis. WJH. 2017;9(36):1332–1339.
   PubMed Web of Science ®Google Scholar
• Morris M, Johnson D, Morrison DS. Opportunities for prevention of alcohol-related death in primary care: results from a population-based cross-sectional study. Alcohol. 2012;46(7):703–707.
   PubMed Web of Science ®Google Scholar
• Verrill C, Smith S, Sheron N. Are the opportunities to prevent alcohol related liver deaths in the UK in primary or secondary care? A retrospective clinical review and prospective interview study. Subst Abuse Treat Prev Policy. 2006;1(1):16.
   PubMed Web of Science ®Google Scholar
• Harman DJ, Ryder SD, James MW, Wilkes EA, et al. Obesity and type 2 diabetes are important risk factors underlying previously undiagnosed cirrhosis in general practice: a cross-sectional study using transient elastography. Aliment Pharmacol Ther. 2018;47(4):504–515.
   PubMed Web of Science ®Google Scholar
• O’Sullivan JW, Stevens S, Hobbs FDR, et al. Temporal trends in use of tests in UK primary care, 2000-15: retrospective analysis of 250 million tests. BMJ. 2018;363:k4666.
   PubMed Web of Science ®Google Scholar
• Dam Fialla A, Schaffalitzky de Muckadell OB, Touborg Lassen A. Incidence, etiology and mortality of cirrhosis: a population-based cohort study. Scandinavian J Gastroenterol. 2012;47(6):702–709.
   PubMed Web of Science ®Google Scholar
• Lackner C, Spindelboeck W, Haybaeck J, et al. Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease. J Hepatol. 2017;66(3):610–618.
   PubMed Web of Science ®Google Scholar
• Newsome PN, Cramb R, Davison SM, et al. Guidelines on the management of abnormal liver blood tests. Gut. 2018;67(1):6–19.
   PubMed Web of Science ®Google Scholar
• Udell JA, Wang CS, Tinmouth J, et al. Does this patient with liver disease have cirrhosis? JAMA. 2012;307(8):832–842.
   PubMed Web of Science ®Google Scholar
• Harris R, Harman DJ, Card TR, et al. Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review. Lancet Gastroenterol Hepatol. 2017;2(4):288–297.
   PubMed Web of Science ®Google Scholar
• Harman DJ, Ryder SD, James MW, Jelpke M, et al. Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography. BMJ Open. 2015;5(4):e007516.
   PubMed Web of Science ®Google Scholar
• Morling JR, Fallowfield JA, Guha IN, et al. Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study. J Hepatol. 2014;60(2):384–391.
   PubMed Web of Science ®Google Scholar
• Caballería L, Pera G, Arteaga I, et al. High prevalence of liver fibrosis among European adults with unknown liver disease: a population-based study. Clin Gastroenterol Hepatol. 2018;16(7):1138–1145.
   PubMed Web of Science ®Google Scholar
• Thiele M, Madsen BS, Hansen JF, et al. Accuracy of the enhanced liver fibrosis test vs fibrotest, elastography, and indirect markers in detection of advanced fibrosis in patients with alcoholic liver disease. Gastroenterology. 2018;154(5):1369–1379.
   PubMed Web of Science ®Google Scholar
• Thiele M, Detlefsen S, Sevelsted ML, et al. Transient and 2-dimensional shear-wave elastography provide comparable assessment of alcoholic liver fibrosis and cirrhosis. Gastroenterology. 2016;150(1):123–133.
   PubMed Web of Science ®Google Scholar
• Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology . 2005;41(6):1313–1321.
   PubMed Web of Science ®Google Scholar
• Ahmed Z, Ahmed U, Walayat S, et al. Liver function tests in identifying patients with liver disease. CEG. 2018;11:301–307.
   Google Scholar
• Whitfield JB, Masson S, Liangpunsakul S, et al. Evaluation of laboratory tests for cirrhosis and for alcohol use, in the context of alcoholic cirrhosis. Alcohol. 2018;66:1–7.
   PubMed Web of Science ®Google Scholar
• Thiele M, Rausch V, Fluhr G, et al. Controlled attenuation parameter and alcoholic hepatic steatosis: diagnostic accuracy and role of alcohol detoxification. J Hepatol. 2018;68(5):1025–1032.
   PubMed Web of Science ®Google Scholar
• Forns X, Ampurdanès S, Llovet JM, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology. 2002;36(4):986–992.
   PubMed Web of Science ®Google Scholar
• Wai C-T, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518–526.
   PubMed Web of Science ®Google Scholar
• Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43(6):1317–1325.
   PubMed Web of Science ®Google Scholar
• Saunders JB, Aasland OG, Babor TF, et al. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption–II. Addiction. 1993;88(6):791–804.
   PubMed Web of Science ®Google Scholar
• Mayfield D, McLeod G, Hall P. The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatry. 1974;131(10):1121–1123.
   PubMed Web of Science ®Google Scholar